Chalumeau M - Search Results

1

[Community acquired pneumonia and influenza in children].

Pons-Catalano C, Vallet C, Lorrot M, Soulier M, Moulin F, Marc E, Chalumeau M, Raymond J, Lebon P, Gendrel D. Pons-Catalano C, et al. Among authors: chalumeau m. Arch Pediatr. 2003 Dec;10(12):1056-60. doi: 10.1016/j.arcped.2003.09.032. Arch Pediatr. 2003. PMID: 14643533 French.

2

Mediastinal aspergilloma ten years after thoracic surgery.

Chalumeau M, Adamsbaum C, Raymond J, Iniguez JL, Gendrel D. Chalumeau M, et al. Pediatr Infect Dis J. 2000 Jul;19(7):662-4. doi: 10.1097/00006454-200007000-00020. Pediatr Infect Dis J. 2000. PMID: 10917230 No abstract available.

3

[Procalcitonin and viral meningitis: reduction of unnecessary antibiotics by measurement during an outbreak].

Marc E, Ménager C, Moulin F, Stos B, Chalumeau M, Guérin S, Lebon P, Brunet F, Raymond J, Gendrel D. Marc E, et al. Among authors: chalumeau m. Arch Pediatr. 2002 Apr;9(4):358-64. doi: 10.1016/s0929-693x(01)00793-x. Arch Pediatr. 2002. PMID: 11998420 French.

4

Rib fractures after chest physiotherapy for bronchiolitis or pneumonia in infants.

Chalumeau M, Foix-L'Helias L, Scheinmann P, Zuani P, Gendrel D, Ducou-le-Pointe H. Chalumeau M, et al. Pediatr Radiol. 2002 Sep;32(9):644-7. doi: 10.1007/s00247-002-0755-y. Epub 2002 Jul 12. Pediatr Radiol. 2002. PMID: 12195303

5

[Mucolytic agents for acute respiratory tract infections in infants: a pharmacoepidemiologic problem?].

Chalumeau M, Chéron G, Assathiany R, Moulin F, Bavoux F, Bréart G, Pons G. Chalumeau M, et al. Arch Pediatr. 2002 Nov;9(11):1128-36. doi: 10.1016/s0929-693x(02)00091-x. Arch Pediatr. 2002. PMID: 12503503 French.

6

Fluoroquinolone safety in pediatric patients: a prospective, multicenter, comparative cohort study in France.

Chalumeau M, Tonnelier S, D'Athis P, Tréluyer JM, Gendrel D, Bréart G, Pons G; Pediatric Fluoroquinolone Safety Study Investigators. Chalumeau M, et al. Pediatrics. 2003 Jun;111(6 Pt 1):e714-9. doi: 10.1542/peds.111.6.e714. Pediatrics. 2003. PMID: 12777590 Clinical Trial.

7

Fluoroquinolones in paediatrics: a risk for the patient or for the community?

Gendrel D, Chalumeau M, Moulin F, Raymond J. Gendrel D, et al. Among authors: chalumeau m. Lancet Infect Dis. 2003 Sep;3(9):537-46. doi: 10.1016/s1473-3099(03)00736-9. Lancet Infect Dis. 2003. PMID: 12954559 Review.

8

[Information recorded by maternity ward staff in permanent pediatric health records].

Chalumeau M, Assathiany R, Francoual C, Benazet M, Gendrel D, Bréart G; groupe Arepege. Chalumeau M, et al. Arch Pediatr. 2003 Sep;10(9):776-80. doi: 10.1016/s0929-693x(03)00300-2. Arch Pediatr. 2003. PMID: 12972204 French.

9

[An example of hospital-based pharmacoepidemiology in paediatrics: tolerance to fluoroquinolones].

Chalumeau M, Gendrel D, Bréart G, Pons G. Chalumeau M, et al. Arch Pediatr. 2004 Jun;11(6):500-2. doi: 10.1016/j.arcped.2004.03.045. Arch Pediatr. 2004. PMID: 15158810 French. No abstract available.

10

Procalcitonin as a predictor of vesicoureteral reflux in children with a first febrile urinary tract infection.

Leroy S, Adamsbaum C, Marc E, Moulin F, Raymond J, Gendrel D, Bréart G, Chalumeau M. Leroy S, et al. Among authors: chalumeau m. Pediatrics. 2005 Jun;115(6):e706-9. doi: 10.1542/peds.2004-1631. Epub 2005 May 2. Pediatrics. 2005. PMID: 15867014

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

206 results

Search Page

Filters